All Companies

Companysort icon Description Status Initial Date
<a href="/venture-capital/all-companies/mascoma-corporation">Mascoma Corporation</a> Leading technology for the conversion of biomass to fuels and chemicals. Private 2006 View Profile
<a href="/venture-capital/all-companies/midori-renewables-inc">Midori Renewables Inc.</a> Deploying Breaking the Biomass Barrier™ technology that melts and digests biomass into sugars. Private 2009 View Profile
<a href="/venture-capital/all-companies/moderna">Moderna</a> Pioneering an entirely new drug modality using messenger RNA therapeutics™. Private 2010 View Profile
<a href="/venture-capital/all-companies/morphotek-inc">Morphotek, Inc.</a> Genetically diverse organisms for agricultural, life science, and pharmaceutical use Acquired 2001 View Profile
<a href="/venture-capital/all-companies/novomer-inc">Novomer, Inc.</a> Commercializing a family of low-cost, high-performance, sustainable polymers and other chemicals. Private 2007 View Profile
<a href="/venture-capital/all-companies/oasys-water-inc">Oasys Water, Inc.</a> Leading the world in the development of forward osmosis based solutions for the treatment and desalination of high saline source waters. Private 2009 View Profile
<a href="/venture-capital/all-companies/ontogeny-inc">Ontogeny, Inc.</a> Developmental biology insights for regenerative medicine therapies Acquired 1994 View Profile
<a href="/venture-capital/all-companies/permeon-biologics-inc">Permeon Biologics Inc.</a> Pioneering a breakthrough class of intracellular biologics that target a broad spectrum of previously undruggable targets. Private 2011 View Profile
<a href="/venture-capital/all-companies/perseptive-biosystems">PerSeptive BioSystems</a> Developer of high-technology purification, analysis and synthesis products Acquired 1991 View Profile
<a href="/venture-capital/all-companies/pervasis-therapeutics-inc">Pervasis Therapeutics, Inc.</a> Developing novel therapeutics to promote vascular repair. Private 2003 View Profile
<a href="/venture-capital/all-companies/pronutria">Pronutria</a> Transforming medicine with ProNutrein™ products, protein nutrients identified in the human diet, for the dietary management of disease. Private 2010 View Profile
<a href="/venture-capital/all-companies/quanterix-corporation">Quanterix Corporation</a> Developing ground-breaking tools in high definition diagnostics. Private 2007 View Profile
<a href="/venture-capital/all-companies/quantum-designs">Quantum Designs</a> Commercializing breakthrough, innovative products in human nutrition. Private 2012 View Profile
<a href="/venture-capital/all-companies/receptos-inc">Receptos, Inc.</a> Developing therapeutic candidates for the treatment of immune and metabolic diseases. Public 2009 View Profile
<a href="/venture-capital/all-companies/renovis">Renovis</a> Discovery, development and commercialization of druts to treat neurological diseases and disorders Public 2000 View Profile
<a href="/venture-capital/all-companies/resolvyx-pharmaceuticals-inc">Resolvyx Pharmaceuticals, Inc.</a> Developing resolvins, a novel class of therapies to treat inflammatory diseases and their complications. Private 2005 View Profile
<a href="/venture-capital/all-companies/seahorse-bioscience-inc">Seahorse Bioscience, Inc.</a> XF instruments are the industry standard in cellular bioenergetic measurements. Private 2001 View Profile
<a href="/venture-capital/all-companies/selecta-biosciences-inc">Selecta Biosciences, Inc.</a> Developing novel drugs that use immune modulating nanomedicines to generate targeted antigen-specific immune responses to prevent and treat disease. Private 2008 View Profile
<a href="/venture-capital/all-companies/selventa">Selventa</a> Pioneering the development of Systems Diagnostics (SysDx™). Private 2001 View Profile
<a href="/venture-capital/all-companies/seres-health">Seres Health</a> Discovering and developing Ecobiotic® therapeutic products to treat important diseases by targeting the underlying biology of the human microbiome. Private 2012 View Profile